Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 5651 - 5675 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Hexaacylaminosugars LMSL01060002
  • Neisseria meningitidis lipid A
24774162 1713.125499 C88H166N2O25P2
LMSL03000437
  • 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT16(26:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52930274 2169.92184 C138H256O16
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AT04
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260767 1968.091862 C92H165N3O41
Gangliosides LMSP0601DT02
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262701 1836.972081 C84H148N4O39
Ascarosides LMFA13040027
  • 15R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-hexadecanoic acid
  • ascr#28
86289699 78966 402.29814 C22H42O6
Gangliosides LMSP0601FG07
  • NeuGcalpha2-8NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262994 1951.040161 C90H158N4O41
LMSL03001260
  • 2-octadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-6-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-2'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-alpha,alpha-trehalose
  • PAT18(24:0(2Me[R],3OH[R],4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S]))
52931097 2247.98992 C141H266O18
Gangliosides LMSP0601CN02
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262469 1707.929487 C79H141N3O36
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BG05
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3(Galbeta1-3GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260864 2418.276825 C110H195N5O52
Diacylglycerophosphoinositolglycans LMGP15010086
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/14:0)
126457454 1146.631483 C54H99O23P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BE01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261660 1388.802768 C66H120N2O28
Other Neutral glycosphingolipids LMSP05000012
  • 1-O-melibiosoyl-(N-(2R-hydroxy-heneicosanoyl)-4R-hydroxy-17-methyl-sphing-6E-enine)
  • Galalpha1-6Glcbeta-Cer(t19:1/21:0(2OH[R])
171120236 963.685824 C51H97NO15
Gangliosides LMSP0601FZ00
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1313
Gangliosides LMSP0601DM01
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262644 1866.982646 C85H150N4O40
Gangliosides LMSP0601CU01
  • GQ1b(d18:1/16:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262524 2391.131619 C104H178N6O55
Gangliosides LMSP0601CX04
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262551 2008.09801 C93H165N5O41
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AF08
  • Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260211 1730.022992 C84H151N3O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AU03
  • Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261598 1444.865368 C70H128N2O28
Gangliosides LMSP0601CS06
  • NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262513 2240.1927 C103H181N5O47
Diacylglycosylglycerophospholipids LMGP14010013
  • 1,2-di-eicosanoyl-sn-glycero-3-phospho-(1'-glycerol-3'-)5-deoxy-5-(dimethylarsinyl)-beta-D-ribofuranoside
  • As-PL(20:0/20:0)
1070.637969 C53H104O14PAs
Gangliosides LMSP0601GR03
  • Galalpha1-3(NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44263254 1939.040161 C89H158N4O41
Gangliosides LMSP0601BH02
  • Gal-GD1b(d18:1/18:0)
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262229 1999.024906 C90H158N4O44
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AV08
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260787 1876.080902 C90H161N3O37
Diacylglycerophosphoinositolglycans LMGP15010076
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:2(9Z,12Z)/16:1(9Z))
126457444 1156.615833 C55H97O23P
LMSL03001227
  • 2-octadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-6-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
  • PAT18(24:0(2Me[R],3OH[R],4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
52931064 2187.932405 C138H258O17

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024